ENTERO HEALTHCARE SOLU L

Entero Healthcare Solutions Limited reported strong performance in its Q1 FY27 earnings conference call held on August 10, 2026. Management stated that consolidated revenue grew 38.2% year-on-year to INR 1,940 crores, with organic revenue growth at 17.8% and inorganic growth at 20.4%. EBITDA margin reached 5%, achieving the full-year guidance in the first quarter. Management highlighted that gross margin expanded by 147 basis points to 11.4%, driven by procurement efficiencies and a growing MedTech business. Profit after tax increased by 72% year-on-year to INR 52 crores. Management emphasized a focus on organic growth and consolidating existing operations, while remaining open to future acquisition opportunities. The company aims for a consolidated revenue growth of approximately 23% year-on-year for FY27, alongside maintaining an EBITDA margin of 5%.

Management emphasized strong growth and margin improvements in the quarter.